CD44 and neoplasm: Compared with the control group, the immune cells in the tumor microenvironment that promote tumor progression, such as MDSCs,53 B cells54, and CD4+ T cells,55 were significantly reduced, whereas the immune cells that have antitumor roles, such as CD8+ T cells56 and CD44+ memory T cells,57 were significantly increased.